FMS News and Press, Fresenius Medical Care AG From 02/09/22

FMS, an underfollowed company from Germany, is the world’s leading provider of products and services for patients with renal diseases. It controls the entire value chain from the manufacturing of dialysis equipment to a global network of more than 4,000 dialysis clinics. Th...

The coronavirus pandemic has accelerated innovations and the adoption of advanced technologies in the healthcare sector. Moreover, national healthcare spending in the United States has increased significantly. The healthcare market is growing and shows promising prospects. Healthcare stocks F...

Inflation concerns have started to affect market sentiment, but it is highly uncertain if that will lead to a real market correction or just some short-term dips. I am continuing my monthly investment plans while still awaiting a market correction or possibly a real crash once market ...

‘WeAudit’ program recognized for excellence and innovation in enhancing patient care Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, was presented with the prestigious Australian Coun...

Fresenius Medical Care’s new mobile app is designed to respond to the unique needs of frontline healthcare teams. Research demonstrates nurse engagement correlates directly with critical safety, quality, and patient experience outcomes. 1 The new digital platform en...

Fear has returned to Wall Street, with the market falling 4% in a matter of days as the Wall of Worry starts to take its toll. Fortunately, the world's highest quality blue chips, including dividend aristocrats, can help you sleep well at night while enjoying generous, dependable, and...

Although Fresenius could raise its guidance and reported solid third quarter results, the stock declined pretty steeply in the last few weeks. Fresenius still has extremely high debt levels on its balance sheet and is facing headwinds due to COVID-19 again. But the stock is tradin...

Fresenius Medical Care (NYSE:FMS) has restructured its operating model with changes to the management board effective Jan. 01, 2022. German-based healthcare services provider focused on renal care has established two new units operating globally: Care Delivery segment and Care Enablement segm...

Inflation concerns have started to affect market sentiment, but it is highly uncertain if that will lead to a real market correction or just some short-term dips. I am continuing my monthly investment plans while still awaiting a market correction or possibly a real crash once market ...

Tweedy, Browne’s 13F portfolio value decreased from $3.56B to $2.99B this quarter. They decreased Alibaba Group Holdings and Baidu while increasing Fresenius Medical Care. They also added FMC Corp. Alphabet Inc. at ~19% of the portfolio is the largest position. For fu...